Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children’s hepatic tumors international collaboration database-Reference-Cited by-同舟云学术

Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children’s hepatic tumors international collaboration database

Published:2024-10 Issue: Volume:76 Page:102811
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Hiyama Eiso^ORCID,Hishiki Tomoro,Yoshimura Kenichi,Krailo Mark,Maibach Rudolf,Haeberle Beate,Rangaswami Arun,Lopez-Terrada Dolores,Malogolowkin Marcio H.,Ansari Marc,Alaggio Rita,O’Neill Allison F.,Trobaugh-Lotrario Angela D.,Watanabe Kenichiro,Schmid Irene,Ranganathan Sarangarajan,Tanaka Yukichi,Inoue Takeshi,Piao Jin,Lin Jason,Czauderna Piotr,Meyers Rebecka L.,Aronson Daniel C.

Publisher

Elsevier BV

Reference44 articles.

1. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children’s Cancer Group and the Pediatric Oncology Group;Ortega;J Clin Oncol,2000

2. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2;Perilongo;Eur J Cancer,2004

3. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese study group for pediatric liver tumor) protocol-1: a report from the Japanese study group for pediatric liver tumor;Sasaki;J Pediatr Surg,2002

4. Outcome and late complications of hepatoblastomas treated using the Japanese study group for pediatric liver tumor 2 protocol;Hiyama;J Clin Oncol,2020

5. High dose chemotherapy with autologous stem cell transplantation in hepatoblastoma does not improve outcome. Results of the GPOH study HB99;Haberle;Klin Padiatr,2019